Clinical Trials Directory

Trials / Completed

CompletedNCT04272567

Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension

Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients Undergoing Cesarean Section: a Randomized, Placebo-controlled Dose-finding Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
99 (actual)
Sponsor
General Hospital of Ningxia Medical University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the suitable infusion dose of norepinephrine for prophylaxis against post-spinal anesthesia hypotension.

Detailed description

Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylactic measures are not taken. Vasopressors has been highly recommended for routine prevention and/or treatment of post-spinal anesthesia hypotension. As a potential substitute drug for phenylephrine, norepinephrine has gradually been used in parturients undergoing cesarean section. There's some evidence that prophylactic infusion of norepinephrine could effectively reduce the incidence of post-spinal anesthesia hypotension in parturients undergoing cesarean section. But the ideal infusion dose of norepinephrine is still unknown. The purpose of this study is to investigate the suitable infusion dose of norepinephrine for prophylaxis against post-spinal anesthesia hypotension.

Conditions

Interventions

TypeNameDescription
DRUGNorepinephrineSimultaneous with subarachnoid block, a bolus of 6μg norepinephrine was given followed by different infusion dose of norepinephrine.
DRUGNormal salineSimultaneous with subarachnoid block, a bolus of 1ml normal saline was given followed by normal saline infusion

Timeline

Start date
2020-03-28
Primary completion
2020-06-30
Completion
2020-06-30
First posted
2020-02-17
Last updated
2020-08-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04272567. Inclusion in this directory is not an endorsement.